"Neostigmine-resistant Curarization"

Middle East Journal of Anesthesiology

Volumn 22, Issue 2, 2013, Pages 131-134

  Baraka, Anis ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; TUBOCURARINE CHLORIDE;

CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EDITORIAL; HUMAN; METHODOLOGY; NEUROMUSCULAR BLOCKING; PARALYSIS; POSTOPERATIVE COMPLICATION;

CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; NEOSTIGMINE; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PARALYSIS; POSTOPERATIVE COMPLICATIONS; TUBOCURARINE;

EID: 84884336671     PISSN: 05440440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (18)

1. Hunter AR: Neostigmine-resistant curarization. Br M J; 1956, 2:919.
2. Churchill-Davison HC: The causes and treatment of prolonged apnea. Anesthesiology; 1959, 20:535.
3. Baraka A: Irreversible tubocurarine neuromuscular block in the human. Br J Anaesth; 1967, 39:891-3.
4. Baraka A: Irreversible curarization. Anaesthesia and Intensive Care; 1977, 5 (no. 3): 244-246.
5. Baraka A: Neostigmine and tubocurarine neuromuscular block. Br J Anaesth; 1981, 53:1005-1006.
6. Baraka A: Neuromuscular block in different species. Acta Anaesth Scand; 1972, 16:132-139.
7. Waser PG: Receptor localization by autoradiographic technique. Ann NY Acad Sci; 1967, 144:737.
8. Bom A, Bradley M, Cameron K, et al: A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angewandte Chemie Inernational Edition; 2002, 41:565-70.
9. Booij LHD: Cyclodextrins and the emergence of sugammadex. Anaesthesia; 2009, 64(supp. 1):31-37.
10. Paton WDM, Waud DR: The margin of safety of neuromuscular transmission. J Physiol; 1967, 191:59.
11. Kopman AF, Eikermann M: Antagonism of non-depolarizing neuromuscular block, current practice. Anaesthesia; 2009, 64(supp. 1):22-30.
12. Eikermann M, Fassbender P, Malhotra A, et al: Unwarranted administration of acetylcholinesterase inhibitions can impair genioglassus and diaphragm muscle function. Anesthesiology; 2007, 107:621-9.
13. Berg H, Viby-Mogensen J, Raed J, et al: Residual neuromuscular block is a risk factor for postoperative pulmonary complications. Acta Anaesthesiologica Scandinavica; 1977, 41:1095-103.
14. Ali HH, Utting JE, Gray C: Stimulus frequency in the detection of neuromuscular block in humans. Br J Anaesth; 1970, 42:967-78.
15. Claudius C, Garvey LH, Viby-Mogensen J: The undesirable effects of neuromuscular blocking drugs. Anaesthesia; 2009, 64(supp. 1):10-21.
16. Tamari JW, Tomey GF, Ibrahim ZM, Baraka A, Jabbur SJ, Bahuth N: Correlative study of the physiologic and morphologic characteristics of the temporal and masseter muscles of the cat. Journal of Dental Research; 1973, vol. 52, no. 3:538-543.
17. Engbaek J, Ostergaard D, Viby-Mogensen J: Double burst stimulation (DBS) a new pattern of nerve stimulation to identify residual neuromuscular block. British Journal of Anaesthesia; 1989, 62:274-8.
18. Drenk NE, Ueda N, Olssen NV, et al: Manual evaluations of residual curarization using double burst stimulation: a comparison with train of four. Anesthesiology; 1989, 70:578-82.